Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Pickkers

Showing results (21-30 of 497) with videos related to

Pageof 50
Sort By:
Shock (Augusta, Ga.)|December 18, 2009
Adenosine-mediated attenuation of the innate immune response for only those who need it? The tailored potential of pentoxifyllineBart P Ramakers, Peter Pickkers
BMJ (Clinical Research Ed.)|February 14, 2018
Man flu: less inflammation but more consequences in men than womenLucas T van Eijk, Peter Pickkers
Nephron. Clinical Practice|October 25, 2014
The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injuryEsther Peters, Rosalinde Masereeuw, Peter Pickkers
The Lancet. Respiratory Medicine|January 28, 2014
Hope for haloperidol in deliriumMark van den Boogaard, Peter Pickkers
Intensive Care Medicine|November 21, 2018
What's new in immunostimulating strategies in the ICUPeter Pickkers, Tom van der Poll
Frontiers in Immunology|March 10, 2018
Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for SepsisChristopher Geven, Matthijs Kox, Peter Pickkers
Intensive Care Medicine|December 12, 2018
Correction to: What's new in immunostimulating strategies in the ICUPeter Pickkers, Tom van der Poll
Current Opinion in Critical Care|November 5, 2025
The therapeutic horizon of acute kidney injury in critical care: exploring pathology, promises, pitfalls, and progressYvo Vogelaar, Louis Mourisse, Peter Pickkers
International Journal of Antimicrobial Agents|February 21, 2016
Reply to: Re: The challenge of Clostridium difficile infection: overview of clinical manifestations, diagnostic tools and therapeutic optionsNynke Postma, Dorien Kiers, Peter Pickkers
International Journal of Antimicrobial Agents|November 28, 2015
The challenge of Clostridium difficile infection: Overview of clinical manifestations, diagnostic tools and therapeutic optionsNynke Postma, Dorien Kiers, Peter Pickkers
Pageof 50

Showing results (21-30 of 497) with videos related to

Sort By:
Pageof 50
Shock (Augusta, Ga.)|December 18, 2009
Adenosine-mediated attenuation of the innate immune response for only those who need it? The tailored potential of pentoxifyllineBart P Ramakers, Peter Pickkers
BMJ (Clinical Research Ed.)|February 14, 2018
Man flu: less inflammation but more consequences in men than womenLucas T van Eijk, Peter Pickkers
Nephron. Clinical Practice|October 25, 2014
The potential of alkaline phosphatase as a treatment for sepsis-associated acute kidney injuryEsther Peters, Rosalinde Masereeuw, Peter Pickkers
The Lancet. Respiratory Medicine|January 28, 2014
Hope for haloperidol in deliriumMark van den Boogaard, Peter Pickkers
Intensive Care Medicine|November 21, 2018
What's new in immunostimulating strategies in the ICUPeter Pickkers, Tom van der Poll
Frontiers in Immunology|March 10, 2018
Adrenomedullin and Adrenomedullin-Targeted Therapy As Treatment Strategies Relevant for SepsisChristopher Geven, Matthijs Kox, Peter Pickkers
Intensive Care Medicine|December 12, 2018
Correction to: What's new in immunostimulating strategies in the ICUPeter Pickkers, Tom van der Poll
Current Opinion in Critical Care|November 5, 2025
The therapeutic horizon of acute kidney injury in critical care: exploring pathology, promises, pitfalls, and progressYvo Vogelaar, Louis Mourisse, Peter Pickkers
International Journal of Antimicrobial Agents|February 21, 2016
Reply to: Re: The challenge of Clostridium difficile infection: overview of clinical manifestations, diagnostic tools and therapeutic optionsNynke Postma, Dorien Kiers, Peter Pickkers
International Journal of Antimicrobial Agents|November 28, 2015
The challenge of Clostridium difficile infection: Overview of clinical manifestations, diagnostic tools and therapeutic optionsNynke Postma, Dorien Kiers, Peter Pickkers
Pageof 50